Trinity Biotech PLC (TRIB)
2.04
+0.06
(+3.03%)
USD |
NASDAQ |
Mar 28, 16:00
1.98
-0.06
(-2.94%)
After-Hours: 20:00
Trinity Biotech Revenue (TTM): 71.39M for Sept. 30, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
September 30, 2023 | 71.39M |
June 30, 2023 | 72.42M |
March 31, 2023 | 73.93M |
December 31, 2022 | 74.78M |
September 30, 2022 | 66.32M |
June 30, 2022 | 72.62M |
March 31, 2022 | 83.05M |
December 31, 2021 | 92.96M |
September 30, 2021 | 106.21M |
June 30, 2021 | 116.22M |
March 31, 2021 | 106.40M |
December 31, 2020 | 101.98M |
September 30, 2020 | 90.53M |
June 30, 2020 | 83.11M |
March 31, 2020 | 89.59M |
December 31, 2019 | 90.44M |
September 30, 2019 | 93.64M |
June 30, 2019 | 92.76M |
March 31, 2019 | 95.26M |
December 31, 2018 | 97.04M |
September 30, 2018 | 97.06M |
June 30, 2018 | 98.96M |
March 31, 2018 | 99.40M |
December 31, 2017 | 99.14M |
September 30, 2017 | 98.27M |
Date | Value |
---|---|
June 30, 2017 | 98.79M |
March 31, 2017 | 99.63M |
December 31, 2016 | 99.61M |
September 30, 2016 | 100.87M |
June 30, 2016 | 100.50M |
March 31, 2016 | 98.47M |
December 31, 2015 | 100.20M |
September 30, 2015 | 101.94M |
June 30, 2015 | 103.34M |
March 31, 2015 | 105.09M |
December 31, 2014 | 104.87M |
September 30, 2014 | 103.65M |
June 30, 2014 | 100.61M |
March 31, 2014 | 95.91M |
December 31, 2013 | 91.22M |
September 30, 2013 | 86.58M |
June 30, 2013 | 83.32M |
March 31, 2013 | 82.81M |
December 31, 2012 | 82.51M |
September 30, 2012 | 81.70M |
June 30, 2012 | 80.67M |
March 31, 2012 | 79.32M |
December 31, 2011 | 77.95M |
September 30, 2011 | 77.18M |
June 30, 2011 | 76.10M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
66.32M
Minimum
Sep 2022
116.22M
Maximum
Jun 2021
88.08M
Average
90.44M
Median
Dec 2019
Revenue (TTM) Benchmarks
Amarin Corp PLC | 306.91M |
Avadel Pharmaceuticals PLC | -- |
DBV Technologies SA | -- |
Adaptimmune Therapeutics PLC | 60.28M |
Biodexa Pharmaceuticals Plc | 0.6446M |